Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's disease.

Dulai PS, Bamias G, Jairath V, Buisson A, Meyer M, Lindner D, Agboton C, Peyrin-Biroulet L.

Open source

DOI
10.1177/17562848261436120
Published
2026-05-04
Container
Ther Adv Gastroenterol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17562848261436120,
  title = {Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's disease.},
  author = {Dulai PS and  Bamias G and  Jairath V and  Buisson A and  Meyer M and  Lindner D and  Agboton C and  Peyrin-Biroulet L.},
  year = {2026},
  journal = {Ther Adv Gastroenterol},
  doi = {10.1177/17562848261436120},
  url = {https://doi.org/10.1177/17562848261436120}
}

RIS

TY  - JOUR
TI  - Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's disease.
AU  - Dulai PS
AU  -  Bamias G
AU  -  Jairath V
AU  -  Buisson A
AU  -  Meyer M
AU  -  Lindner D
AU  -  Agboton C
AU  -  Peyrin-Biroulet L.
PY  - 2026
JO  - Ther Adv Gastroenterol
DO  - 10.1177/17562848261436120
UR  - https://doi.org/10.1177/17562848261436120
ER  - 

APA

PS, D., G, B., V, J., A, B., M, M., D, L., C, A., & L., P. (2026). Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's disease.. Ther Adv Gastroenterol. https://doi.org/10.1177/17562848261436120

Source records